Written by Sudhavana S., Deepak P
Parent Category: Year 2012, Volume 4
Category: Year 2012, Volume 4, Issue 2, May-August 2012
ntroduction: Cardiovascular disease is the leading cause of death in type2 diabetes (DM). Microalbuminuria (MA) is strongly associated with cardiovascular complications in type2 diabetes. Impaired cardiovascular autonomic function and increased albumin excretion are related in patients with diabetes. So this study is designed to investigate the relationship between cardiovascular autonomic function and microalbuminuria in type2 diabetes.
Methods: The study comprised of 180 subjects of age group>50 years, classified into 3 groups of 60 subjects each. DM without MA, DM with MA and controls. The tests performed were 1) Heart rate response to deep breathing, valsalva maneuver and standing; 2) Blood pressure response to standing and to sustained handgrip. Individual tests were given score of 0, 1, or 2 and an overall autonomic test score of 0-10 was obtained.
Results: Mean autonomic score in control, DM without MA and DM with MA are 1.97 ± 0.81, 5.73 ± 1.26 and 7.00 ± 1.80 respectively. The Coefficient of variation (%) of control, DM without MA, DM with MA is 41.1, 21.9 and 25.7 respectively. A significant difference in autonomic score was observed in the DM without MA (P<0.01) and DM with MA (P<0.01) when compared to controls.
Conclusion: In conclusion type2 diabetic individuals should be diagnosed early to prevent disease progression to microalbuminuria and thus minimize complications..
Key words: Cardiovascular autonomic function; Microalbuminuria; Type 2 diabetes
Nike Air Max 90 Candy DripΑνδρικά Nike
Volume 12, Issue 4, October-December 2020
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
The most recent editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: